Keywords: generex, begins, dosing, pivotal, ph, iii, oral-lyn

Generex begins dosing in pivotal Ph III Oral-lyn trial

Article | 21 July 2008

Print This

The USA's Generex Biotechnology has initiated dosing of over one hundred patients in the pivotal Phase III clinical trial of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in